{"id": 1, "score1": 3, "score2": 3, "reason": "The sentence mentions \"neurodegenerative disorders\", which is related to AD; there is a mutation type (m6A modifier); it is a conclusive statement.", "statement": "m6A-modified circRNAs can modulate expression of stress response genes (UBC and PPP2CA), which may constitute the mechanistic basis for OS-induced neurodegenerative disorders.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"neurodegenerative disorders\" is associated with AD and indicates that the definitive mutation type is \"modulate expression\" and the entity relationship is \"constitute\". It also contains AD-related keywords such as \"neurodegenerative disorders\" and \"stress response genes\"."}]}
{"id": 2, "score1": 3, "score2": 3, "reason": "The sentence mentions \"patients with AD\", which is related to AD; there is an explicit mutation type (increase in NF-kB activity); the entity relationship is positive (contribute); it is a conclusive statement.", "statement": "The results from in vitro cultured neurons showed an increase in NF-kB activity due to the regulation of miR-338 that might contribute to inflammatory states in patients with AD.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"inflammatory states in patients with AD\" is associated with AD and indicates that the definitive mutation type is \"regulation\" and the entity relationship is \"increase\"."}]}
{"id": 4, "score1": 3, "score2": 3, "reason": "The sentence mentions \"APP\", which is related to AD; there is an explicit mutation type (lack); the entity relationship is positive (increases); it is a conclusive statement.", "statement": "In addition, FMRP regulates Adam10 mRNA translation, and lack of FMRP in mice (Fmr1 KO) increases both APP and ADAM10 protein levels.", "gpt-3.5-turbo": [{"index": 0, "content": "[Score and Rationale]: 3 points; The statement is a conclusive statement in that \"FMRP, Adam10, APP, ADAM10 protein levels\" are associated with AD and it indicates that the definitive mutation type is \"lack of FMRP\" and the entity relationship is \"increases\"."}]}
{"id": 5, "score1": 3, "score2": 3, "reason": "Sentence mentioning \"APP\" is related to AD; there is a clear mutation type (absence); the entity relationship is positive (exaggerated); it is a conclusive statement.", "statement": "FMRP mediates mGluR5-dependent translation of APP mRNA, and its absence leads to exaggerated APP expression in Fmr1 KO mice and individuals with FXS.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"FMRP, APP mRNA\" is associated with AD and indicates that the definitive mutation type is \"absence\" and the entity relationship is \"leads to exaggerated\"."}]}
{"id": 6, "score1": 3, "score2": 3, "reason": "The sentence mentions \"AD\", which is related to AD; the entity relationship is positive (overproduction); it is a conclusive statement.", "statement": "However, a large body of research suggests that other genetic components may also be involved in the manifestation of AD, such as mutations in amyloid-beta precursor protein (AbetaPP), presenilin1, and presenilin 2 genes attributing to the overproduction of Abeta plaques.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"AD\" and \"mutations in amyloid-beta precursor protein (AbetaPP), presenilin1, and presenilin 2 genes\". It also indicates that the definitive mutation type is \"mutations\" and the entity relationship is \"overproduction\"."}]}
{"id": 7, "score1": 3, "score2": 3, "reason": "Sentence mentions \"App\", which is related to AD; there is a defined mutation type (depletion); entity relationship is positive/negative (upregulated/downregulated); it is a conclusive statement.", "statement": "We found that Pon1 depletion significantly downregulated Phf8 and upregulated H4K20me1; mTOR, phospho-mTOR, and App were upregulated while autophagy markers Bcln1, Atg5, and Atg7 were downregulated at the protein and mRNA levels in the brains of Pon1 / 5xFAD vs. Pon1+/+5xFAD mice.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"App\", \"mTOR\", \"autophagy markers\", and \"brains\". It also indicates that the definitive mutation type is \"depletion\" and the entity relationships are \"downregulated\" and \"upregulated\"."}]}
{"id": 8, "score1": 3, "score2": 3, "reason": "The sentence mentions \"neuroblastoma\", which is related to AD; there is a defined mutation type (depletion); the entity relationship is positive/negative (upregulated/downregulated); it is a conclusive statement.", "statement": "Notably, Pon1 depletion caused changes in the Phf8- > H4K20me1- > mTOR- > autophagy pathway akin to the changes induced by HHcy in the mouse brain (Figure 1) and neuroblastoma cells (Figure 3).", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation type is \"depletion\", but it does not contain a clear entity relationship and cannot be determined to be AD-related content."}]}
{"id": 10, "score1": 3, "score2": 3, "reason": "The sentence mentions \"Abeta peptide\", which is related to AD; there is a definite mutation type (dysfunction); the entity relationship is positive (increase); it is a conclusive statement.", "statement": "An alternative explanation would be that enzymes involved in Abeta peptide processing may bind to circAPP (hsa_circ_0007556), so that circAPP (hsa_circ_0007556) would control the availability of them; a circAPP (hsa_circ_0007556) dysfunction would lead to the release of the enzymes, resulting in an increase of Abeta.", "gpt-3.5-turbo": [{"index": 0, "content": "[Score and Rationale]: 0 points; The statement does not contain any AD-related keywords and does not provide any information about AD-related genes, proteins, or mutations."}]}
{"id": 12, "score1": 3, "score2": 3, "reason": "Sentence mentions \"plaques and tangles, as well as cognitive impairments\", which is related to AD; there is a definite mutation type (3xTg-AD); the entity relationship is positive (developed); and it is a conclusive statement.", "statement": "3xTg-AD mice harbour three mutant genes for the beta-amyloid precursor protein (betaAPPSwe), presenilin-1 (PS1M146V), and tauP301L; as a consequence, the mice progressively develop plaques and tangles, as well as cognitive impairments.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"AD\", \"beta-amyloid precursor protein\", \"presenilin-1\", \"tau\", \"plaques\", \"tangles\", and \"cognitive impairments\". It also indicates that the definitive mutation types are \"betaAPPSwe\", \"PS1M146V\", and \"tauP301L\", and the entity relationship is \"develop\"."}]}
{"id": 13, "score1": 3, "score2": 3, "reason": "Sentence mentions \"AD\", which is related to AD; has a defined mutation type (APP-PS1 transgenic); entity relationship is positive (upregulated); is a conclusive statement", "statement": "Recently, it has been demonstrated that the expression of MAPK/p38alpha protein is upregulated in the brain of APP-PS1 transgenic AD mouse, whereas the knockdown of MAPK in the APP-PS1 mouse stimulates macroautophagy/autophagy, reducing amyloid pathology by increasing autophagic-lysosomal degradation of BACE1.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"AD, MAPK/p38alpha protein\" is associated with AD and indicates that the definitive mutation type is \"upregulated\" and the entity relationship is \"reducing\"."}]}
{"id": 18, "score1": 3, "score2": 3, "reason": "Sentence mentions \"AD\", which is related to AD; there is a clear type of mutation (MiRNAs deregulation); conclusive statement", "statement": "MiRNAs deregulation linked with AD in two ways; (i) the deregulation of miRNAs could be initiated by AD pathogenic factors such as Abeta, p-tau, inflammation, aging, oxidative stress, and mitochondrial DNA damage, and/or (ii) the genetic alteration of miRNAs could be a contributing factor in AD progression.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"AD, miRNAs, Abeta, p-tau, inflammation, aging, oxidative stress, mitochondrial DNA damage\" and describes the relationship between miRNA deregulation and AD pathogenic factors. It states that the relationship can be initiated by AD pathogenic factors or genetic alterations of miRNAs."}]}
{"id": 22, "score1": 3, "score2": 3, "reason": "Sentence mentions \"neuroinflammation and amyloidogenesis\", which is related to AD; there is a definite mutation type (streptozotocin treatment); the entity relationship is negative (decrease); it is a conclusive statement", "statement": "Likewise, streptozotocin treatment in a rat astrocytoma cell line, resulted in an IR mRNA decrease and protein expression, and induced neuroinflammation and amyloidogenesis.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"neuroinflammation and amyloidogenesis\" are associated with AD, and it indicates that the definitive mutation type is \"streptozotocin treatment\" and the entity relationship is \"decrease and induced\"."}]}
{"id": 47, "score1": 3, "score2": 3, "reason": "Sentence mentions \"PD\", which is related to AD; there is a defined mutation type (monoallelic GBA1 mutations); concluding statement;", "statement": "In contrast, monoallelic GBA1 mutations are present in ~ 10% of the patients affected by PD, representing thus the main genetic risk for PD and linking GCase dysfunction to alpha-synuclein accumulation.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"PD, GBA1 mutations\" is associated with AD and indicates that the definitive mutation type is \"monoallelic\" and the entity relationship is \"linking\"."}]}
{"id": 48, "score1": 3, "score2": 3, "reason": "Sentence mentions \"neurodegeneration\", which is related to AD; there is a clear mutation type (loss of functional); concluding statement;", "statement": "Therefore, the loss of functional GCase creates a noxious circle of glucosylceramide and alpha-synuclein accumulation that ultimately leads to ALP dysfunction and neurodegeneration.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"ALP dysfunction and neurodegeneration\" is associated with AD, and it indicates that the definitive mutation type is \"loss of functional GCase\" and the entity relationship is \"creates a noxious circle\"."}]}
{"id": 50, "score1": 3, "score2": 3, "reason": "The sentence mentions \"memory\", which is associated with AD; there is a defined mutation type (Inhibition of CCR5/overexpression); the entity relationship is positive/negative (increased); it is a conclusive statement.", "statement": "Inhibition of CCR5 increased MAPK/CREB signaling and enhanced memory, whereas CCR5 overexpression resulted in memory impairment and decreased plasticity.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"memory impairment\" and \"decreased plasticity\" are associated with AD, and it indicates that the definitive mutation type is \"inhibition\" and \"overexpression\" with the entity relationship of \"increased\" and \"decreased\"."}]}
{"id": 3, "score1": 2, "score2": 2, "reason": "There is an explicit mutation type (over expression); the entity relationship is negative (causes the loss of); a conclusive statement; but there is no AD-related keyword.", "statement": "The over expression of miR-181c-5p causes the loss of mt-COX1 protein and results in an imbalance in ROS generation.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"imbalance in ROS generation\" is associated with AD and indicates that the definitive mutation type is \"overexpression\" and the entity relationship is \"causes the loss\"."}]}
{"id": 9, "score1": 2, "score2": 2, "reason": "Sentence mentions \"AD\", which is related to AD; it is a conclusive statement.", "statement": "The former constitutes 5% of AD cases and is characterized by mutations in the Amyloid Precursor Protein (APP), Presenilin 1 (PSEN1) or Presenilin 2 (PSEN2) genes, all of which are related to the synthesis and processing of Abeta-peptide.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords (AD, APP, PSEN1, PSEN2) and indicates that the definitive mutation type is \"mutations\" and the entity relationship is \"related to the synthesis and processing\"."}]}
{"id": 11, "score1": 2, "score2": 2, "reason": "There is an explicit mutation type (overexpression); the entity relationship is positive (increased); concluding statement; but no AD-related keywords", "statement": "It has been demonstrated that TSPO overexpression in Jurkat cells resulted in increased gene expression of mitochondrial ETC molecules and ATP production, thus evidencing TSPO involvement in mitochondrial energy metabolism.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation type is \"overexpression\", but it does not contain a clear entity relationship and cannot be determined to be AD-related content."}]}
{"id": 14, "score1": 2, "score2": 2, "reason": "There is a definite mutation type (knockdown); the entity relationship is negative (downregulate); conclusive statement; but no AD-related keyword", "statement": "Accordingly, the knockdown of CYP1A1 has been found to downregulate ERK and PI3K/AKT pathways and to induce the AMPK pathway, leading to a reduction in tumor progression and cancer cell survival.", "gpt-3.5-turbo": [{"index": 0, "content": "0 points; The statement does not contain any AD-related keywords and does not provide any information related to AD or its pathogenesis."}]}
{"id": 15, "score1": 2, "score2": 2, "reason": "There is a clear mutation type (loss of function); the entity relationship is positive (promote); a conclusive statement; but no AD-related keywords are present.", "statement": "This study implies that the loss of function of Zfp90 might promote cisplatin sensitization in OC cells via regulating the Nrf2/HO-1 pathway to enhance cell apoptosis and inhibit the migrative effect in both SK-OV-3 and ES-2 cells.", "gpt-3.5-turbo": [{"index": 0, "content": "0 points; The statement does not contain any AD-related keywords and does not provide any information about AD or its associated genes or proteins."}]}
{"id": 16, "score1": 2, "score2": 2, "reason": "There is a clear mutation type (knockdown); the entity relationship is positive (enhanced); concluding statement; but there is no AD-related keyword.", "statement": "Our data indicated that 10, 15 and 20 muM cisplatin could significantly inhibit SK-OV-3 cell viability (*, p < 0.05, versus si-Ctrl group) and the knockdown of Zfp90 significantly enhanced cisplatin-induced cytotoxicity in both the 24 h treatment (1, 10, 15 and 20 muM) (Figure 1A) and the 48 h treatment (1, 10, 15 and 20 muM) (Figure 1B) (#, p < 0.05, versus same concentration cisplatin in si-Ctrl group individually).", "gpt-3.5-turbo": [{"index": 0, "content": "0 points; The statement does not contain any AD-related keywords or clear mutation type and entity relationship."}]}
{"id": 21, "score1": 2, "score2": 2, "reason": "Sentence mentions \"Alzheimer's disease\", which is related to AD; there is a clear mutation type (demethylation); it is a conclusive statement.", "statement": "Because dysregulated mTOR signaling and autophagy have been implicated in Abeta accumulation in Alzheimer's disease, and H4K20me1 demethylation by PHF8 is important for maintaining homeostasis of mTOR signaling, we studied how these processes are affected by Pon1 depletion in the mouse neuroblastoma N2a-APPswe cells and Pon1 / 5xFAD mice.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"Alzheimer's disease\", \"Abeta accumulation\", \"mTOR signaling\", \"autophagy\", \"PHF8\", \"Pon1 depletion\", \"N2a-APPswe cells\", and \"Pon1 / 5xFAD mice\". It also indicates that the definitive mutation type is \"depletion\" and the entity relationship is \"affected\"."}]}
{"id": 23, "score1": 2, "score2": 2, "reason": "There is a definite mutation type (variant B); entity relationship is positive (increased); conclusive statement; but no AD-related keywords", "statement": "These findings suggest that the presence of variant B at the mitochondria leads to increased susceptibility towards agents or stresses that compromise ATP production.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation type is \"variant B\" and the entity relationship is \"increased susceptibility\", but it does not contain AD-related keywords."}]}
{"id": 25, "score1": 2, "score2": 2, "reason": "There is a definite mutation type (knockdown); the entity relationship is positive (improve); concluding statement; but no AD-related keywords.", "statement": "The pharmacological inhibition of MLYCD activity and the knockdown of the Mlycd gene improve the biomechanical functions of the post-ischemic heart.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation type is \"knockdown\" and the entity relationship is \"improve\", but it does not contain AD-related keywords."}]}
{"id": 42, "score1": 2, "score2": 2, "reason": "There is a clear type of mutation (Loss); the entity relationship is negative (disrupts); a concluding statement; but there is no AD-related keyword.", "statement": "Loss of alphaII-spectrin disrupts the periodicity of betaIV-spectrin at the nodal gap and of betaII-spectrin at paranodes, impairs NoR assembly and maintenance, disrupts the restricted juxtaparanode localization of KV1.2 and causes axon degeneration.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"axon degeneration\" and \"spectrin\". It indicates that the definitive mutation type is \"loss\" and the entity relationship is \"disrupts\"."}]}
{"id": 43, "score1": 2, "score2": 2, "reason": "There is a clear mutation type (Loss); entity relationships are positive (increase); concluding statement; but no AD-related keywords", "statement": "Loss of ankyrin-B results in a twofold increase in dendritic betaII-spectrin in DIV10 neurons without overall changes in its total brain expression or in the organization of the axonal MPS.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation type is \"Loss\" and the entity relationship is \"increase\", but it does not contain AD-related keywords."}]}
{"id": 44, "score1": 2, "score2": 2, "reason": "With a specific mutation type (knockdown); entity relationships are negative (decreases); concluding statement; but no AD-related keywords", "statement": "Consistent with a functional role for betaIII-spectrin in spines, its knockdown decreases the density of dendritic spines and alters the formation of the constricted necks of spines in hippocampal neuronal cultures.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"betaIII-spectrin\" is associated with AD and indicates that the definitive mutation type is \"knockdown\" and the entity relationship is \"decreases\" and \"alters\"."}]}
{"id": 17, "score1": 1, "score2": 1, "reason": "Sentence mentions \"early onset-AD\", which is related to AD; conclusive statement", "statement": "According to a research article published in 2021, mutations found in APP, PS1 and PS2 are associated with early onset-AD, whereas age related factors such as ROS production, mitochondrial DNA changes and epigenetic factors have been observed in sporadic AD.", "gpt-3.5-turbo": [{"index": 0, "content": "[Score and Rationale]: 3 points; The statement contains AD-related keywords such as \"APP, PS1, PS2, early onset-AD, sporadic AD\" and provides information about the relationship between mutations and AD. The mutation types are explicitly mentioned as \"mutations found in APP, PS1 and PS2\"."}]}
{"id": 19, "score1": 1, "score2": 1, "reason": "Entity relationship is positive (displayed); conclusive statement; but no AD-related keywords", "statement": "In addition, fibroblasts from an ALS patient with a CHCHD10 mutation displayed mitochondrial ultrastructural damage and mitochondrial network fragmentation.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"ALS, CHCHD10 mutation\" is associated with AD and indicates that the definitive mutation type is \"CHCHD10 mutation\" and the entity relationship is \"displayed\"."}]}
{"id": 20, "score1": 1, "score2": 1, "reason": "Sentence mentions \"AD\", is related to AD;  is a conclusive statement", "statement": "The comparison of allelic and genotypic frequencies between AD patients and controls confirmed the APOE_epsilon4 allele as the main genetic variant risk for the development of AD (p = 0.029) (Table 2).", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"AD, APOE_epsilon4 allele\" is associated with AD and indicates that the definitive mutation type is \"genetic variant risk\" and the entity relationship is \"confirmed as the main genetic variant risk\"."}]}
{"id": 24, "score1": 1, "score2": 1, "reason": "Entity relationship is positive (positively regulate); concluding statement;", "statement": "Likewise, NFI proteins were shown to positively regulate transcription by recruiting histone acetylases and nucleosome remodeling enzymes (e.g., NURF) and to drive an increase in active chromatin modifications, such as H3K4me3 and H3K36me3.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation type is \"positively regulate\" and the entity relationship is \"increase\", but it does not contain AD-related keywords."}]}
{"id": 26, "score1": 1, "score2": 1, "reason": "Sentence mentions \"Alzheimer's disease\", which is related to AD; conclusive statement", "statement": "Both amyloid precursor protein (APP) and presenilin (PSEN) gene mutations are associated with familial Alzheimer's disease (FAD) and with the early onset of the disease.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"Alzheimer's disease\", \"amyloid precursor protein (APP)\", \"presenilin (PSEN)\", \"familial Alzheimer's disease (FAD)\", and \"early onset\". It also indicates that the definitive mutation types are \"APP and PSEN gene mutations\" and the entity relationship is \"associated with\"."}]}
{"id": 27, "score1": 1, "score2": 1, "reason": "Sentence mentions \"Alzheimer's disease\", which is related to AD; conclusive statement", "statement": "Cross-sectional analyses from the Cretan Aging Cohort (CAC) revealed significant associations between objective long sleep duration and executive deficits among persons diagnosed with MCI and cognitively non-impaired individuals, whereas long sleep duration in MCI and Alzheimer's Disease (AD) patients may be driven by the presence of APOE (Apolipoprotein E) epsilon4 allele.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement contains AD-related keywords such as \"Alzheimer's Disease\", \"MCI\", and \"APOE epsilon4 allele\". It also indicates a relationship between the APOE epsilon4 allele and long sleep duration in MCI and AD patients."}]}
{"id": 28, "score1": 1, "score2": 1, "reason": "There is a specific mutation type (rs2241883 CC genotype); a conclusive statement; but there are no AD-related keywords", "statement": "showed that the rs2241883 CC genotype of FABP1 gene is associated with dyslipidemia and Xue et al.", "gpt-3.5-turbo": [{"index": 0, "content": "0 points; The statement does not contain any AD-related keywords and does not provide any information about the pathogenesis of AD."}]}
{"id": 30, "score1": 1, "score2": 1, "reason": "Entity relationship is positive (develop); concluding statement; but no AD-related keywords", "statement": "Prior studies have also illustrated that women with harmful BRCA1 (39-44%) or BRCA2 (11-17%) variants will develop OC easily at 70-80 years old.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation types are \"BRCA1\" and \"BRCA2\" variants, but it does not contain a clear entity relationship and cannot be judged to be associated with AD."}]}
{"id": 34, "score1": 1, "score2": 1, "reason": "Specific mutation type (Inhibition of insulin signalling); conclusive statement; but no AD-related keywords", "statement": "By contrast, inhibition of insulin signalling in the brain has an orexigenic effect, it increases food intake, and as a result increases the body weight.", "gpt-3.5-turbo": [{"index": 0, "content": "[Score and Rationale]: 0 points; The statement does not contain any AD-related keywords and does not provide any information about AD or its associated genes or proteins."}]}
{"id": 36, "score1": 1, "score2": 1, "reason": "Specific mutation type (knockout); concluding statement; but no AD-related keywords", "statement": "The knockout of the Acsf3 gene in HEK 293T cells was found to alter their metabolism.", "gpt-3.5-turbo": [{"index": 0, "content": "0 points; The statement does not contain any AD-related keywords and does not provide any information about AD or its associated genes or proteins."}]}
{"id": 46, "score1": 1, "score2": 1, "reason": "There is a specific mutation type (Biallelic GBA1 mutation); concluding statement; but no AD-related keywords", "statement": "Biallelic GBA1 mutation causes Gaucher's disease, mendelian disorders affecting several organs and tissues due to cells accumulating fatty substances.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"Gaucher's disease\" is associated with AD and it states that the type of mutation in the gene is \"biallelic mutation\" and the entity relationship is \"causes\"."}]}
{"id": 49, "score1": 1, "score2": 1, "reason": "Sentence mentioning \"Abeta\", associated with AD; concluding statement;", "statement": "Abeta monomers assemble into oligomers and polymers, mainly Abeta40 and Abeta42, and ultimately form insoluble neurotoxic amyloid plaques.", "gpt-3.5-turbo": [{"index": 0, "content": "3 points; The statement is a conclusive statement in that \"Abeta monomers\" is associated with AD and indicates that the definitive mutation type is \"assemble into oligomers and polymers\" and the entity relationship is \"form insoluble neurotoxic amyloid plaques\"."}]}
{"id": 29, "score1": 0, "score2": 0, "reason": "Does not contain a specific mutation type; entity relationship is neutral; no AD-related keywords", "statement": "Pathogenic variations in the BRCA1 and BRCA2 responsible for most OC syndromes have been reported in numerous ethnic groups.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement indicates that the definitive mutation types are \"pathogenic variations\" and the entity relationship is \"responsible\", but it does not contain AD-related keywords."}]}
{"id": 31, "score1": 0, "score2": 0, "reason": "Does not contain a specific mutation type; entity relationship is neutral; no AD-related keywords", "statement": "Furthermore, the modulation of Zfp90 impacted the BMP4 and some oncogenic related pathways in CRC mouse models and patients.", "gpt-3.5-turbo": [{"index": 0, "content": "[Score and Rationale]: 0 points; The statement does not contain any AD-related keywords and does not provide any information about AD or its associated genes or proteins."}]}
{"id": 32, "score1": 0, "score2": 0, "reason": "Does not contain a specific mutation type, entity relationship is neutral, no AD-related keywords", "statement": "Exclusion of genetic disorders mimicking ALS, such as spinal and bulbar muscular atrophy (SBMA) which is caused by a polyglutamine expansion in the androgen receptor (AR) gene and can be mistaken for LMN-predominant ALS.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement does not contain AD-related keywords, but it does mention a specific gene mutation (polyglutamine expansion in the androgen receptor gene) and indicates that it can be mistaken for a specific clinical manifestation (LMN-predominant ALS)."}]}
{"id": 33, "score1": 0, "score2": 0, "reason": "Does not contain a specific mutation type, entity relationship is neutral, no AD-related keywords", "statement": "The five miRNAs:miR-130a, miR-130b, miR-140, miR-320 and miR-494:were identified as mitochondrial enriched miRNAs, and most of them are involved in the expression of genes associated with apoptosis, cell proliferation, and differentiation.", "gpt-3.5-turbo": [{"index": 0, "content": "2 points; The statement contains two key elements: miRNAs and their involvement in gene expression. However, it does not contain any AD-related keywords and does not provide a clear mutation type or entity relationship."}]}
{"id": 35, "score1": 0, "score2": 0, "reason": "Sentence mentions \"AD\" and is related to AD; not a conclusive statement but a future development", "statement": "In any case, it would be interesting to study several aspects of this circRNA, such as the expression of the protein that originates from circAPP (hsa_circ_0007556), the methylation of circAPP (hsa_circ_0007556), since it has been demonstrated that m6A RNA methylation can efficiently promote translation to proteins or the interaction of this circRNA with other molecules to try to elucidate its function in the brain and its role in AD.", "gpt-3.5-turbo": [{"index": 0, "content": "[Score and Rationale]: 2 points; The statement does not contain AD-related keywords, but it includes two key elements: the expression of the protein and the methylation of circAPP."}]}
{"id": 37, "score1": 0, "score2": 0, "reason": "Does not contain a specific type of mutation, entity relationship is neutral, no AD-related keywords", "statement": "Likewise, a rare variant of melatonin receptor 1b (MTNR1B) has been recently identified and is associated with impaired glucose tolerance and an increased risk of type 2 DM.", "gpt-3.5-turbo": []}
{"id": 38, "score1": 0, "score2": 0, "reason": "Sentence mentions \"AD\" and is related to AD; not a concluding statement but a future development", "statement": "In order to estimate whether the variants of the circadian genes plus the presence of the APOE_epsilon4 allele were associated with faster AD progression, patients were grouped according to their APOE_epsilon4 carrier status (carriers vs. non-carriers).", "gpt-3.5-turbo": []}
{"id": 39, "score1": 0, "score2": 0, "reason": "Sentence mentions \"AD\", AD-related; not a conclusive statement, but a future development", "statement": "Herein, we aimed to determine the association between genetic variants of APOE, PER2, PER3 and OX2R with BPSD in patients with AD and paired cognitively healthy controls.", "gpt-3.5-turbo": []}
{"id": 40, "score1": 0, "score2": 0, "reason": "Sentence mentions \"AD\" in relation to AD; not a concluding statement, but a future development", "statement": "In the present study, we expanded the information about frequencies of BPSD in Mexican patients with AD and their association with APOE, PER2, PER3 and OX2R gene variants in both AD patients and cognitively healthy controls.", "gpt-3.5-turbo": []}
{"id": 41, "score1": 0, "score2": 0, "reason": "Sentence mentioning \"AD\", related to AD; not a conclusive statement, but a future development", "statement": "To study the involvement of PON1 in the development of AD and to elucidate the mechanism involved, we generated a new mouse model of AD, the Pon1-/-xFAD mouse, and examined how Pon1 depletion affects mTOR signaling, autophagy, and amyloid beta (Abeta) accumulation.", "gpt-3.5-turbo": []}
{"id": 45, "score1": 0, "score2": 0, "reason": "Does not contain a specific mutation type, entity relationship is neutral, no AD-related keywords", "statement": "Some mendelian forms of PD result from mutations in ALP genes e.g., ATP13A2, LRRK2 or VPS35.", "gpt-3.5-turbo": []}
